TARA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 15:51):

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases...

Stats
Today's Volume	90 026.00
Average Volume	290 955
Market Cap	60.33M
EPS	$0 ( 2024-05-02 )
Next earnings date	( $-0.810 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.820
ATR14	$0.0110 (0.37%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-19	Shefferman Jesse	Buy	59 000	Common Stock
2024-01-19	Shefferman Jesse	Sell	7 803	Common Stock
2024-01-19	Shefferman Jesse	Buy	357 000	Stock Option (Right to Buy)
2024-01-19	Bandari Jathin	Buy	137 000	Stock Option (Right to Buy)
2024-01-19	Bandari Jathin	Buy	23 000	Common Stock

INSIDER POWER
91.94
Last 95 transactions
Buy: 2 372 974 \| Sell: 114 915

Volume Correlation

Long: 0.28 (neutral)

Short: 0.85 (strong)

Signal:(38.853) Same movement expected

Protara Therapeutics Inc Correlation

10 Most Positive Correlations
PXLW	0.933
SRTS	0.925
KTCC	0.915
IMNM	0.908
LXRX	0.907
FWRG	0.905
KYMR	0.903
SWTX	0.897
COHR	0.892
NWSA	0.892

10 Most Negative Correlations
RTPY	-0.921
RMRM	-0.872
KVSB	-0.863
DSWL	-0.86
SGML	-0.857
VALN	-0.857
SRNGW	-0.856
BFRI	-0.856
BSGM	-0.854
BIOL	-0.853

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Protara Therapeutics Inc Correlation - Currency/Commodity

-0.63
( weak negative )

-0.58
( weak negative )

0.00
( neutral )

-0.51
( weak negative )

-0.34
( neutral )

0.48
( neutral )

Protara Therapeutics Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-341 000 (0.00 %)
EPS:	$-3.57

FY	2023
Revenue:	$0
Gross Profit:	$-341 000 (0.00 %)
EPS:	$-3.57

FY	2022
Revenue:	$0
Gross Profit:	$-247 000 (0.00 %)
EPS:	$-5.76

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-6.53

Financial Reports:

No articles found.

Protara Therapeutics Inc

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.